Global Targeted Bisulfite Sequencing Service Market Growth (Status and Outlook) 2025-2031

According to this study, the global Targeted Bisulfite Sequencing Service market size will reach US$ 1015 million by 2031.

Targeted Bisulfite Sequencing Service is an epigenetic analysis method that combines bisulfite conversion with next-generation sequencing (NGS) to detect DNA methylation at single-base resolution within specific genomic regions. During bisulfite treatment, unmethylated cytosines are converted to uracil, while methylated cytosines remain unchanged. The converted DNA is then PCR-amplified and sequenced, enabling precise methylation profiling of targeted loci. Compared to whole-genome bisulfite sequencing, the targeted approach offers cost-efficiency, higher coverage depth, and focused data output. This service is widely used in biomarker validation, early cancer detection, developmental biology, and disease mechanism studies, providing a powerful tool for high-resolution, site-specific DNA methylation analysis.

United States market for Targeted Bisulfite Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Targeted Bisulfite Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Targeted Bisulfite Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Targeted Bisulfite Sequencing Service players cover CD Genomics, Eurofins Scientific, BGI, BioCat GmbH, Zymo Research, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Targeted Bisulfite Sequencing Service Industry Forecast” looks at past sales and reviews total world Targeted Bisulfite Sequencing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted Bisulfite Sequencing Service sales for 2025 through 2031. With Targeted Bisulfite Sequencing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Bisulfite Sequencing Service industry.

This Insight Report provides a comprehensive analysis of the global Targeted Bisulfite Sequencing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Bisulfite Sequencing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Bisulfite Sequencing Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Bisulfite Sequencing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Bisulfite Sequencing Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Bisulfite Sequencing Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
PCR Amplification Method
Probe Hybridization Capture Method

Segmentation by Application:
Research On Tumor Methylation Markers
Research On Stem Cell Differentiation and Development Regulation
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CD Genomics
Eurofins Scientific
BGI
BioCat GmbH
Zymo Research
IGATech
EpigenTek
Creative Biolabs
Macrogen
Diagenode
Active Motif
Cambridge Bioscience

Please note: The report will take approximately 2 business days to prepare and deliver. Show more